GJC3
geneOn this page
Also known as CX30.2CX29
Summary
GJC3 (gap junction protein gamma 3, HGNC:17495) is a protein-coding gene on chromosome 7q22.1, encoding Gap junction gamma-3 protein (Q8NFK1). One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell.
This gene encodes a gap junction protein. The encoded protein, also known as a connexin, plays a role in formation of gap junctions, which provide direct connections between neighboring cells. Mutations in this gene have been reported to be associated with nonsyndromic hearing loss.
Source: NCBI Gene 349149 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 41 total
- MANE Select transcript:
NM_181538
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17495 |
| Approved symbol | GJC3 |
| Name | gap junction protein gamma 3 |
| Location | 7q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CX30.2, CX29 |
| Ensembl gene | ENSG00000176402 |
| Ensembl biotype | protein_coding |
| OMIM | 611925 |
| Entrez | 349149 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000312891
RefSeq mRNA: 1 — MANE Select: NM_181538
NM_181538
CCDS: CCDS34697
Canonical transcript exons
ENST00000312891 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001231504 | 99923266 | 99923603 |
| ENSE00001231513 | 99928840 | 99929620 |
Expression profiles
Bgee: expression breadth ubiquitous, 120 present calls, max score 84.70.
Top tissues by expression
128 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tibial nerve | UBERON:0001323 | 84.70 | gold quality |
| body of pancreas | UBERON:0001150 | 80.55 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 78.85 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.52 | gold quality |
| minor salivary gland | UBERON:0001830 | 76.25 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 75.78 | gold quality |
| sural nerve | UBERON:0015488 | 74.32 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 73.16 | gold quality |
| pancreas | UBERON:0001264 | 70.96 | gold quality |
| prostate gland | UBERON:0002367 | 70.62 | gold quality |
| skin of leg | UBERON:0001511 | 67.94 | gold quality |
| zone of skin | UBERON:0000014 | 66.05 | gold quality |
| liver | UBERON:0002107 | 64.67 | gold quality |
| right lobe of liver | UBERON:0001114 | 64.63 | gold quality |
| placenta | UBERON:0001987 | 64.34 | gold quality |
| skin of abdomen | UBERON:0001416 | 63.83 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 62.50 | gold quality |
| body of stomach | UBERON:0001161 | 62.04 | gold quality |
| adipose tissue | UBERON:0001013 | 60.40 | gold quality |
| fundus of stomach | UBERON:0001160 | 59.49 | gold quality |
| substantia nigra | UBERON:0002038 | 59.24 | gold quality |
| stomach | UBERON:0000945 | 58.87 | gold quality |
| tonsil | UBERON:0002372 | 58.42 | gold quality |
| right lung | UBERON:0002167 | 57.96 | gold quality |
| omental fat pad | UBERON:0010414 | 57.74 | gold quality |
| testis | UBERON:0000473 | 55.84 | gold quality |
| left testis | UBERON:0004533 | 55.78 | gold quality |
| left coronary artery | UBERON:0001626 | 55.45 | gold quality |
| putamen | UBERON:0001874 | 55.45 | gold quality |
| right testis | UBERON:0004534 | 55.35 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 8.03 |
| E-ANND-3 | yes | 4.57 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): TBX3
miRNA regulators (miRDB)
24 targeting GJC3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-221-3P | 99.86 | 71.56 | 1329 |
| HSA-MIR-222-3P | 99.86 | 71.35 | 1337 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-1290 | 99.59 | 69.90 | 2079 |
| HSA-MIR-1915-3P | 99.58 | 66.79 | 1988 |
| HSA-MIR-297 | 99.40 | 69.58 | 1418 |
| HSA-MIR-125A-5P | 99.36 | 70.59 | 1640 |
| HSA-MIR-125B-5P | 99.36 | 70.36 | 1662 |
| HSA-MIR-4717-3P | 99.06 | 66.34 | 1072 |
| HSA-MIR-3926 | 98.95 | 69.26 | 1438 |
| HSA-MIR-942-3P | 98.81 | 69.04 | 876 |
| HSA-MIR-3149 | 98.77 | 67.13 | 1639 |
| HSA-MIR-4520-3P | 98.75 | 66.55 | 963 |
| HSA-MIR-3908 | 98.75 | 67.31 | 1160 |
| HSA-MIR-4450 | 98.26 | 68.35 | 725 |
| HSA-MIR-7154-3P | 97.65 | 65.02 | 985 |
| HSA-MIR-616-3P | 96.82 | 66.99 | 784 |
| HSA-MIR-675-3P | 95.77 | 69.27 | 675 |
Literature-anchored findings (GeneRIF, showing 9)
- Cx31.3 is localized to the gray matter along small myelinated fibers and is co-expressed with Cx32 in oligodendrocytes. (PMID:18353664)
- We suggest that the c.[43C–>G(+)230G–>C] compound heterozygous variant of Cx29 may be a risk factor for the development of hearing loss in Taiwanese. (PMID:19657183)
- Data show that the p.E269D missense mutation resulted in accumulation of the Cx29 mutant protein in the endoplasmic reticulum rather than in the cytoplasmic membrane. (PMID:19876648)
- Mutations in the Cx29 gene do not play a role in the causation of non syndromic hearing impairment in Indian population. (PMID:20632892)
- The connexin30.2/CX31.3 shares functional properties with pannexin (hemi) channels rather than gap junction channels of other Connexins. (PMID:21480002)
- Although p.R15G and p.L23H mutants do not decrease the trafficking of CX proteins, mutations in GJC3 genes result in a loss of hemichannel function of CX30.2/CX31.3 protein, possibly causing hearing loss. (PMID:23179405)
- Based on these findings, we suggest that p.W77S mutant has a dominant negative effect on the formation and function of the gap junction. These results give a novel molecular elucidation for the mutation of GJC3 in the development of hearing loss. (PMID:28367085)
- GJB4 and GJC3 variants in non-syndromic hearing impairment in Ghana. (PMID:32524838)
- Pelizaeus-Merzbacher-Like Disease 1 Caused by a Novel Mutation in GJC2 Gene: A Case Report. (PMID:34840390)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Gjc3 | ENSMUSG00000056966 |
| rattus_norvegicus | Gjc3 | ENSRNOG00000001329 |
Paralogs (20): GJA8 (ENSG00000121634), GJB6 (ENSG00000121742), GJA3 (ENSG00000121743), GJA9 (ENSG00000131233), GJA10 (ENSG00000135355), GJA1 (ENSG00000152661), GJD2 (ENSG00000159248), GJB7 (ENSG00000164411), GJB2 (ENSG00000165474), GJB1 (ENSG00000169562), GJD4 (ENSG00000177291), GJC1 (ENSG00000182963), GJD3 (ENSG00000183153), GJA4 (ENSG00000187513), GJB3 (ENSG00000188910), GJB5 (ENSG00000189280), GJB4 (ENSG00000189433), GJC2 (ENSG00000198835), GJE1 (ENSG00000203733), GJA5 (ENSG00000265107)
Protein
Protein identifiers
Gap junction gamma-3 protein — Q8NFK1 (reviewed: Q8NFK1)
Alternative names: Connexin-30.2, Connexin-31.3, Gap junction epsilon-1 protein
All UniProt accessions (1): Q8NFK1
UniProt curated annotations — full annotation on UniProt →
Function. One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell.
Subunit / interactions. A connexon is composed of a hexamer of connexins.
Subcellular location. Cell membrane. Cell junction. Gap junction.
Tissue specificity. CNS specific. Expression is restricted to brain, spinal cord, and sciatic nerve. According to PubMed:12881038, expression is abundant in skeletal muscle, liver, and heart, and to a minor degree in pancreas and kidney.
Similarity. Belongs to the connexin family. Gamma-type subfamily.
RefSeq proteins (1): NP_853516* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000500 | Connexin | Family |
| IPR013092 | Connexin_N | Domain |
| IPR017990 | Connexin_CS | Conserved_site |
| IPR019570 | Connexin_CCC | Domain |
| IPR038359 | Connexin_N_sf | Homologous_superfamily |
Pfam: PF00029
UniProt features (27 total): helix 9, topological domain 5, transmembrane region 4, turn 3, strand 3, chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
3 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6L3T | ELECTRON MICROSCOPY | 2.34 |
| 6L3U | ELECTRON MICROSCOPY | 2.53 |
| 6L3V | ELECTRON MICROSCOPY | 2.63 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NFK1-F1 | 75.71 | 0.43 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 77 (showing top):
GOBP_CIRCULATORY_SYSTEM_PROCESS, GOBP_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS, GOBP_GROWTH, GOBP_CELL_CELL_SIGNALING, GOBP_CELL_COMMUNICATION_INVOLVED_IN_CARDIAC_CONDUCTION, GOBP_ENSHEATHMENT_OF_NEURONS, GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING, GOBP_ORGAN_GROWTH, GOBP_REGULATION_OF_SYSTEM_PROCESS, GOBP_SENSORY_PERCEPTION, GOBP_HEART_PROCESS, GOBP_SENSORY_ORGAN_DEVELOPMENT, GOCC_CELL_CELL_JUNCTION, GOBP_CARDIAC_CONDUCTION, GOBP_TRANSMEMBRANE_TRANSPORT
GO Biological Process (5): cell-cell signaling (GO:0007267), sensory perception of sound (GO:0007605), myelination (GO:0042552), cell communication (GO:0007154), transmembrane transport (GO:0055085)
GO Molecular Function (3): gap junction channel activity (GO:0005243), identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (6): connexin complex (GO:0005922), myelin sheath (GO:0043209), plasma membrane (GO:0005886), gap junction (GO:0005921), membrane (GO:0016020), anchoring junction (GO:0070161)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular process | 2 |
| cellular anatomical structure | 2 |
| cell communication | 1 |
| signaling | 1 |
| sensory perception of mechanical stimulus | 1 |
| axon ensheathment | 1 |
| transport | 1 |
| wide pore channel activity | 1 |
| protein binding | 1 |
| binding | 1 |
| gap junction | 1 |
| plasma membrane protein complex | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cell-cell junction | 1 |
| cell junction | 1 |
Protein interactions and networks
STRING
346 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GJC3 | KCNA2 | P16389 | 827 |
| GJC3 | AP1S1 | P61966 | 788 |
| GJC3 | GJA5 | P36382 | 487 |
| GJC3 | GJC1 | P36383 | 470 |
| GJC3 | PBXIP1 | Q96AQ6 | 430 |
| GJC3 | PANX1 | Q96RD7 | 428 |
| GJC3 | PANX2 | Q96RD6 | 385 |
| GJC3 | ZMAT2 | Q96NC0 | 382 |
| GJC3 | PMVK | Q15126 | 379 |
| GJC3 | PANX3 | Q96QZ0 | 370 |
| GJC3 | ERMN | Q8TAM6 | 364 |
| GJC3 | LGI4 | Q8N135 | 360 |
| GJC3 | OR10H3 | O60404 | 356 |
| GJC3 | KCNA1 | Q09470 | 348 |
| GJC3 | AZGP1 | P25311 | 347 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MS4A13 | GJC3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX7 | GJC3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MS4A13 | GJC3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| STX7 | GJC3 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (2): GJC3 (Two-hybrid), MS4A13 (Two-hybrid)
ESM2 similar proteins: A3KN25, A4IFL1, O18968, O70491, O75712, O95377, P08033, P25305, P28230, P28231, P28232, P28233, P28234, P28235, P29414, P33725, P35212, P36380, P36382, P41987, Q01231, Q02738, Q02739, Q03190, Q08DF2, Q0V8E7, Q0VCR2, Q29RK8, Q4QR83, Q58D78, Q5E9Z5, Q5R7B4, Q60HF7, Q64448, Q6WGK6, Q7M734, Q80VM9, Q866T7, Q8BSD4, Q8CE93
Diamond homologs: A2VE67, A3KN25, A4GG66, A4GVD1, A4IFL1, A6XKM2, O18968, O57474, O93533, O95377, O95452, P08033, P08034, P08050, P08983, P14154, P16863, P16864, P17302, P18246, P18860, P18861, P21994, P23242, P25305, P28228, P28229, P28230, P28231, P28232, P28233, P28234, P28235, P28236, P29033, P29414, P29415, P33725, P35212, P36381
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
41 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 30 |
| Likely benign | 7 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
644 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:142133846:ACAGG:A | acceptor_loss | 1.0000 |
| 6:142133847:CAGG:C | acceptor_loss | 1.0000 |
| 6:142133849:G:GA | acceptor_loss | 1.0000 |
| 6:142133193:GATGT:G | donor_gain | 0.9900 |
| 6:142133194:ATGT:A | donor_gain | 0.9900 |
| 6:142133194:ATGTG:A | donor_loss | 0.9900 |
| 6:142133195:TGT:T | donor_gain | 0.9900 |
| 6:142133195:TGTGT:T | donor_loss | 0.9900 |
| 6:142133196:GT:G | donor_gain | 0.9900 |
| 6:142133196:GTG:G | donor_gain | 0.9900 |
| 6:142133196:GTGTA:G | donor_loss | 0.9900 |
| 6:142133197:TGT:T | donor_gain | 0.9900 |
| 6:142133198:G:GA | donor_loss | 0.9900 |
| 6:142133198:G:GG | donor_gain | 0.9900 |
| 6:142133199:TA:T | donor_loss | 0.9900 |
| 6:142133200:AA:A | donor_loss | 0.9900 |
| 6:142133837:A:AG | acceptor_gain | 0.9900 |
| 6:142133838:A:G | acceptor_gain | 0.9900 |
| 6:142133840:A:G | acceptor_gain | 0.9900 |
| 6:142133843:A:AG | acceptor_gain | 0.9900 |
| 6:142133844:T:G | acceptor_gain | 0.9900 |
| 6:142133849:GGTT:G | acceptor_gain | 0.9900 |
| 6:142133849:GGTTA:G | acceptor_gain | 0.9900 |
| 7:99923605:T:C | acceptor_gain | 0.9900 |
| 7:99923608:T:TC | acceptor_gain | 0.9900 |
| 7:99928439:A:AC | donor_gain | 0.9900 |
| 7:99928440:C:CC | donor_gain | 0.9900 |
| 6:142133193:G:GT | donor_gain | 0.9800 |
| 6:142133198:GTA:G | donor_gain | 0.9800 |
| 6:142133201:AG:A | donor_loss | 0.9800 |
AlphaMissense
1787 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:99929469:A:C | F51C | 0.958 |
| 7:99929468:G:C | F51L | 0.952 |
| 7:99929468:G:T | F51L | 0.952 |
| 7:99929470:A:G | F51L | 0.952 |
| 7:99929024:G:C | S199R | 0.910 |
| 7:99929024:G:T | S199R | 0.910 |
| 7:99929026:T:G | S199R | 0.910 |
| 7:99929357:G:C | S88R | 0.910 |
| 7:99929357:G:T | S88R | 0.910 |
| 7:99929359:T:G | S88R | 0.910 |
| 7:99929429:G:C | C64W | 0.895 |
| 7:99929082:C:G | C180S | 0.885 |
| 7:99929083:A:T | C180S | 0.885 |
| 7:99929393:G:C | F76L | 0.883 |
| 7:99929393:G:T | F76L | 0.883 |
| 7:99929395:A:G | F76L | 0.883 |
| 7:99929463:C:G | C53S | 0.882 |
| 7:99929464:A:T | C53S | 0.882 |
| 7:99929442:C:G | C60S | 0.879 |
| 7:99929443:A:T | C60S | 0.879 |
| 7:99929533:C:G | G30R | 0.873 |
| 7:99929533:C:T | G30R | 0.873 |
| 7:99929430:C:T | C64Y | 0.865 |
| 7:99929361:G:C | P87R | 0.862 |
| 7:99929178:T:A | E148V | 0.861 |
| 7:99929426:G:C | F65L | 0.854 |
| 7:99929426:G:T | F65L | 0.854 |
| 7:99929428:A:G | F65L | 0.854 |
| 7:99929361:G:T | P87H | 0.853 |
| 7:99929033:A:C | F196L | 0.849 |
dbSNP variants (sampled 300 via entrez): RS1000151093 (7:99925355 G>T), RS1000336889 (7:99931221 G>A), RS1001102546 (7:99926731 A>G), RS1001156367 (7:99926909 A>G), RS1002101702 (7:99927815 G>T), RS1003148176 (7:99926471 A>G), RS1003464720 (7:99922962 G>A), RS1003859634 (7:99930551 T>C), RS1004062579 (7:99924461 G>A,C), RS1004299440 (7:99928003 G>A), RS1004636100 (7:99926893 G>A), RS1004862021 (7:99932182 G>A), RS1005123758 (7:99932453 T>C,G), RS1005475940 (7:99926205 G>A,C), RS1005617875 (7:99927498 C>T)
Disease associations
OMIM: gene MIM:611925 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010002_259 | Refractive error | 3.000000e-16 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: other ic — Connexins and Pannexins
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | increases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Catechin | increases expression, affects cotreatment | 1 |
| Rotenone | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Targeted by drugs: Calcium, Carbenoxolone